Technical Analysis for THOR - Synthorx, Inc.

Grade Last Price % Change Price Change
grade B 19.3 3.54% 0.66
THOR closed up 3.54 percent on Monday, March 25, 2019, on 31 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A Up Down
See historical THOR trend table...

Date Alert Name Type % Chg
Mar 25 MACD Bearish Signal Line Cross Bearish 0.00%
Mar 25 Crossed Above 20 DMA Bullish 0.00%
Mar 25 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Mar 25 Wide Bands Range Expansion 0.00%
Mar 22 Fell Below 20 DMA Bearish 3.54%
Mar 22 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 3.54%
Mar 22 Multiple of Ten Bearish Other 3.54%
Mar 22 Wide Bands Range Expansion 3.54%
Mar 22 Down 3 Days in a Row Weakness 3.54%
Mar 22 Down 4 Days in a Row Weakness 3.54%

Older signals for THOR ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Synthorx, Inc. is a biotechnology company focused on prolonging and improving the lives of people with cancer and autoimmune disorders. Synthorx’s proprietary, first-of-its-kind Expanded Genetic Alphabet platform technology expands the genetic code by adding a new DNA base pair and is designed to create optimized biologics, referred to as Synthorins. A Synthorin is a protein optimized through incorporation of novel amino acids encoded by the new DNA base pair that enables site-specific modifications, which enhance the pharmacological properties of these therapeutics. The company’s lead product candidate, THOR-707, a variant of IL-2, is in development in multiple tumor types as a single agent and in combination with an immune checkpoint inhibitor. The company was founded based on important discoveries in Dr. Floyd Romesberg’s lab at The Scripps Research Institute. The company is headquartered in La Jolla, Calif.
Biotechnology Biopharmaceutical Cancer Life Sciences Biology Immune System Genetics Tumor Platform Technology Autoimmune Disorders Molecular Genetics DNA Genetic Code Immune Checkpoint Nucleic Acids
Is THOR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 23.53
52 Week Low 11.0
Average Volume 160,571
200-Day Moving Average 0.0
50-Day Moving Average 17.1668
20-Day Moving Average 19.0455
10-Day Moving Average 19.555
Average True Range 1.718
ADX 23.35
+DI 25.5616
-DI 22.3513
Chandelier Exit (Long, 3 ATRs ) 17.336
Chandelier Exit (Short, 3 ATRs ) 20.244
Upper Bollinger Band 22.4035
Lower Bollinger Band 15.6875
Percent B (%b) 0.54
BandWidth 35.262923
MACD Line 0.6277
MACD Signal Line 0.6624
MACD Histogram -0.0347
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 21.64
Resistance 3 (R3) 21.41 20.40 21.25
Resistance 2 (R2) 20.40 19.80 20.52 21.12
Resistance 1 (R1) 19.85 19.44 20.13 20.08 20.99
Pivot Point 18.84 18.84 18.98 18.96 18.84
Support 1 (S1) 18.29 18.24 18.57 18.52 17.61
Support 2 (S2) 17.28 17.88 17.40 17.48
Support 3 (S3) 16.73 17.28 17.35
Support 4 (S4) 16.96